Subclinical Hypothyroidism with TSH>7 mIU/l and≤10 mIU/l and Coronary Artery Disease

Abstract

The association of subclinical hypothyroidism (SCH) with increased cardiovascular risk is controversial when thyroid-stimulating hormone (TSH) concentration is<10 mIU/l, as well as its association with a higher coronary artery calcium score (CACS) in individuals with low cardiovascular risk. This study evaluated coronary artery disease (CAD) by CACS in asymptomatic, low-cardiovascular risk women with SCH and TSH>7 mIU/l and≤10 mIU/l untreated for 5 years after diagnosis. The CACS was obtained for two groups of women with low cardiovascular risk. Group A consisted of 32 women with mild SCH (TSH>7 mIU/l and≤10 mIU/l) who remained untreated for 5 years, and group B consisted of 32 euthyroid women matched for age and body mass index to group A. The CACS ranged from 0 to 350 (median 0, 25–75% interval: 0–10) in group A and from 0 to 280 (median 0, 25–75% interval: 0–0) in group B. Scores>0 and≥10 were significantly more frequent in group A (40.6 vs. 12.5% and 25 vs. 3.1%, respectively). A CACS≥100 was also more frequent in group A (18.75 vs. 3.1%), but the difference was not significant (p=0.1). The results of the study suggest that long-term SCH with TSH>7 mIU/l and ≤ 10 mIU/l is associated with a higher risk of CAD in individuals≤65 years, even in those with low cardiovascular risk.

Key words

subclinical hypothyroidism - TSH≤10 mIU/l - coronary artery disease - coronary artery calcium score

• References

• 1 Rodondi N, den Elzen WP, Bauer DC. et al. Thyroid Studies Collaboration. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA 2010; 304: 1365-1374
• 2 Pearce SH, Brabant G, Duntas LH. et al. 2013 ETA Guideline: Management of Subclinical Hypothyroidism. Eur Thyroid J 2013; 2: 215-228
• 3 Peeters RP. Subclinical Hypothyroidism. N Engl J Med 2017; 376: 2556-2565
• 4 Chaker L, Baumgartner C, den Elzen WP. et al. Thyroid Studies Collaboration. Subclinical hypothyroidism and the risk of stroke events and fatal stroke: An individual participant data analysis. J Clin Endocrinol Metab 2015; 100: 2181-2191
• 5 Hecht H, Blaha MJ, Berman DS. et al. Clinical indications for coronary artery calcium scoring in asymptomatic patients: Expert consensus statement from the Society of Cardiovascular Computed Tomography. J Cardiovasc Comput Tomogr 2017; 11: 157-168
• 6 Silverman MG, Blaha MJ, Krumholz HM. et al. Impact of coronary artery calcium on coronary heart disease events in individuals at the extremes of traditional risk factor burden: the Multi-Ethnic Study of Atherosclerosis. Eur Heart J 2014; 35: 2232-2241
• 7 Park YJ, Lee YJ, Choi SI. et al. Impact of subclinical hypothyroidism on the coronary artery disease in apparently healthy subjects. Eur J Endocrinol 2011; 165: 115-121
• 8 Silva N, Santos O, Morais F. et al. Subclinical hypothyroidism represents an additional risk factor for coronary artery calcification, especially in subjects with intermediate and high cardiovascular risk scores. Eur J Endocrinol 2014; 171: 327-334
• 9 Verma R, Verma A, Gupta P. et al. Coronary artery calcium scoring is a better predictor of cardiac risk in subclinical hypothyroidism patients with low-risk Framingham score. Indian J Endocrinol Metab 2016; 20: 756-762
• 10 Peixoto de Miranda EJF, Bittencourt MS, Staniak HL. et al. Thyrotropin levels and coronary artery calcification: cross-sectional results of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Clin Endocrinol 2017; 87: 597-604
• 11 Cooper DS, Biondi B. Subclinical thyroid disease. Lancet 2012; 379: 1142-1154
• 12 Garber JR, Cobin RH, Gharib H. et al. American Association Of Clinical Endocrinologists And American Thyroid Association Taskforce On Hypothyroidism In Adults. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid 2012; 22: 1200-1235
• 13 Brenta G, Vaisman M, Sgarbi JA. et al. Task Force on Hypothyroidism of the Latin American Thyroid Society (LATS). Clinical practice guidelines for the management of hypothyroidism. Arq Bras Endocrinol Metabol 2013; 57: 265-291
• 14 Rosário PW, Carvalho M, Calsolari MR. Natural history of subclinical hypothyroidism with TSH≤10 mIU/l: a prospective study. Clin Endocrinol (Oxf) 2016; 84: 878-881
• 15 Abbara S, Blanke P, Maroules CD. et al. SCCT guidelines for the performance and acquisition of coronary computed tomographic angiography: A report of the society of Cardiovascular Computed Tomography Guidelines Committee: Endorsed by the North American Society for Cardiovascular Imaging (NASCI). J Cardiovasc Comput Tomogr 2016; 10: 435-449
• 16 Anderson TJ, Grégoire J, Pearson GJ. et al. 2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult. Can J Cardiol 2016; 32: 1263-1282
• 17 Grundy SM, Stone NJ, Bailey AL. et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary. Circulation 2019; 139: e1046-e1081
• 18 Razvi S, Weaver JU, Butler TJ. et al. Levothyroxine treatment of subclinical hypothyroidism, fatal and nonfatal cardiovascular events, and mortality. Arch Intern Med 2012; 172: 811-817
• 19 Andersen MN, Olsen AM, Madsen JC. et al. Levothyroxine substitution in patients with subclinical hypothyroidism and the risk of myocardial infarction and mortality. PLoS One 2015; 10: e0129793
• 20 Stott DJ, Rodondi N, Kearney PM. et al. TRUST Study Group Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism. N Engl J Med 2017; 376: 2534-2544
• 21 Grossman A, Feldhamer I, Meyerovitch J. Treatment with levothyroxin in subclinical hypothyroidism is associated with increased mortality in the elderly. Eur J Intern Med 2018; 50: 65-68